Severe hepatitis arising from ipilimumab administration, following melanoma treatment with nivolumab

Ryota Tanaka(University of Tsukuba), Manabu Fujimoto(Osaka Gakuin University), Naoyuki Hasegawa(University of Tsukuba), Ikuo Sekine(University of Tsukuba), Hiroshi Maruyama(Panasonic (Japan)), Sae Inoue(University of Tsukuba), Shusaku Ito(Hitachi General Hospital), Yasuhiro Fujisawa(University of Tsukuba)
Japanese Journal of Clinical Oncology
October 25, 2016
Cited by 56


Related Papers